CD8A and neoplasm: Given that the antitumor effect of the combined blockade of EP2 and EP4 in the ICI-insensitive LLC1 model is independent of CD8+ T cells [27], the contribution of CD8+ T cells is likely affected by the immunological tumor microenvironment, including the tumor's immunogenicity and/or intrinsic sensitivity to ICIs.